The relationship between tumor markers and pulmonary embolism in lung cancer

Wei Xiong; Yunfeng Zhao; Mei Xu; Jian Guo; Bigyan Pudasaini; Xueling Wu; Jinming Liu

doi:10.18632/oncotarget.17916

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

The relationship between tumor markers and pulmonary embolism in lung cancer

Wei Xiong, Yunfeng Zhao, Mei Xu, Jian Guo, Bigyan Pudasaini, Xueling Wu and Jinming Liu _

PDF | HTML | How to cite

Oncotarget. 2017; 8:41412-41421. https://doi.org/10.18632/oncotarget.17916

Metrics: PDF 1971 views | HTML 2592 views | ?

Abstract

Wei Xiong1,*, Yunfeng Zhao2,*, Mei Xu3, Jian Guo4,*, Bigyan Pudasaini1, Xueling Wu5 and Jinming Liu1

1Department of Cardio-Pulmonary Circulation, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

2Department of Respiratory Medicine, Punan Hospital, Pudong New District, Shanghai, China

3Department of Respiratory Medicine, Gongli Hospital, Pudong New District, Second Military Medical University, Shanghai, China

4Department of Pulmonary Function Test, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

5Department of Respiratory Medicine, Renji Hospital, Jiaotong University School of Medicine, Shanghai, China

*Joint first authors

Correspondence to:

Jinming Liu, email: [email protected]

Keywords: tumor markers, pulmonary embolism, lung cancer, panel of combined tumor markers, CEA

Received: March 06, 2017 Accepted: May 01, 2017 Published: May 17, 2017

ABSTRACT

Background: Tumor markers (TMs) and D-Dimer are both hallmarks of severity and prognosis of lung cancer. Tumor markers could be related to pulmonary embolism (PE) in lung cancer.

Results: The number of abnormal tumor markers of lung cancer patients with pulmonary embolism (3.9 ± 1.1vs1.6 ± 0.6,P 0.005) was more than that in patients without pulmonary embolism. TMs panel (P trend < 0.001), CEA (R2 0.735, P0.003) and CYFRA21-1 (R2 0.718, P0.005) were positively correlated with D-Dimer in patients with pulmonary embolism. The multivariate logistic regression analysis showed that, for tumor markers, TMs panel (OR5.98, P < 0.001) had the strongest correlation with pulmonary embolism. The AUC (area under curve) of TMs panel and CEA were 0.82 [95%CI (0.71–0.95), P < 0.001] and 0.71 [95%CI (0.62–0.84), P 0.002] by ROC (receiver operating characteristic) curve analysis, respectively.

Materials and Methods: Tumor markers were compared between lung cancer patients complicated with pulmonary embolism and those without pulmonary embolism Then the correlation between each tumor marker as well as panel of combined TMs and D-Dimer as well as pulmonary embolism were analyzed for patients with pulmonary embolism.

Conclusions: There is a relationship between tumor markers and pulmonary embolism in patients with lung cancer. The panel of combined tumor markers is a valuable diagnostic marker for pulmonary embolism in lung cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17916

Publication Alerts

Research Papers:

The relationship between tumor markers and pulmonary embolism in lung cancer

Abstract